Document is current
Any future updates will be listed below
-
Authors
Quaglia, Fabio
Krishn, Shiv Ram
Sossey-Alaoui, Khalid
Rana, Priyanka Shailendra
Pluskota, Elzbieta
Park, Pyung Hun
Shields, Christopher D.
Lin, Stephen
McCue, Peter
Kossenkov, Andrew V.
Wang, Yanqing
Goodrich, David W.
Ku, Sheng-Yu
Beltran, Himisha
Kelly, William K.
Corey, Eva
Klose, Maja
Bandtlow, Christine
Liu, Qin
Altieri, Dario C.
Plow, Edward F.
Languino, Lucia R.
- License Information
-
More Information
Article History
Received: 27 December 2021
Accepted: 30 September 2022
First Online: 7 November 2022
Competing interests
: HB has served as consultant/advisory board member for Janssen, Sanofi Genzyme, Astellas, Astra Zeneca, Merck, Pfizer, Foundation Medicine, Blue Earth, and has received research funding from Janssen Oncology (Inst), AbbVie/Stemcentrx (Inst), Eli Lilly (Inst), Millennium Pharmaceuticals (Inst). DWG has a sponsored research agreement with Celgene/BMS. EC received research funding from, Janssen Research and Development, Bayer Pharmaceuticals, KronosBio, Forma Pharmaceutics Foghorn, Gilead, Sanofi, AbbVie, and GSK (all Inst.). All other authors have declared that no relevant conflict of interest exists.
